Peer-Reviewed Journal Details
Mandatory Fields
Henry, RJ,Kerr, DM,Finn, DP,Roche, M
2016
January
Progress In Neuro-Psychopharmacology & Biological Psychiatry
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
Published
Optional Fields
2-AG Anandamide Depression LPS Poly I:C Schizophrenia CANNABINOID CB2 RECEPTORS MURINE ENCEPHALOMYELITIS VIRUS INDUCED SICKNESS BEHAVIOR MESSENGER-RNA EXPRESSION N-ARACHIDONOYL DOPAMINE ANXIETY-LIKE BEHAVIORS RAT MICROGLIAL CELLS NITRIC-OXIDE THEILERS VIRUS TNF-ALPHA
64
167
180
Toll-like receptors (TLRs) mediate the innate immune response to pathogens and are critical in the host defence, homeostasis and response to injury. However, uncontrolled and aberrant TLR activation can elicit potent effects on neurotransmission and neurodegenerative cascades and has been proposed to trigger the onset of certain neurodegenerative disorders and elicit detrimental effects on the progression and outcome of established disease. Over the past decade, there has been increasing evidence demonstrating that the endocannabinoid system can elicit potent modulatory effects on inflammatory processes, with clinical and preclinical evidence demonstrating beneficial effects on disease severity and symptoms in several inflammatory conditions. This review examines the evidence supporting a modulatory effect of endocannabinoids on TLR-mediated immune responses both peripherally and centrally, and the implications for psychiatric disorders such as depression and schizophrenia. (C) 2015 Elsevier Inc. All rights reserved.
10.1016/j.pnpbp.2015.03.006
Grant Details
Publication Themes